Literature DB >> 20803698

High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study.

Jarrad Wilson1, Christopher Hair, Ross Knight, Anthony Catto-Smith, Sally Bell, Michael Kamm, Paul Desmond, John McNeil, William Connell.   

Abstract

BACKGROUND: To date, there have been no population-based epidemiological studies published from Australia concerning the incidence of inflammatory bowel disease (IBD). Our hypothesis was that the incidence of IBD in Australia is at least as high as other industrialized countries, given similar genetic and environmental risk factors.
METHODS: A prospective, population-based IBD incidence study was conducted between April 2007 and March 2008 in Greater Geelong, Victoria, Australia. According to 2006 Australian Census data, this comprises an at-risk population of 259,015. Cases were ascertained from multiple overlapping sources. All local general practitioners, gastroenterologists, surgeons, and pediatricians were contacted every 2 months to identify new IBD cases. The Royal Children's Hospital in Melbourne, local endoscopy and pathology centers were also searched to ensure completeness of case capture. Standard IBD case definitions were used with clinical, endoscopic, and histological criteria.
RESULTS: In all, 76 new cases of IBD were identified during the 1-year period. There were 45 cases of Crohn's disease, 29 of ulcerative colitis, and 2 of indeterminate colitis. The crude annual incidence rates for IBD overall, Crohn's disease, ulcerative colitis, and indeterminate colitis were 29.3 per 100,000 (95% confidence interval [CI] 23.5-36.7 per 100,000), 17.4 per 100,000, 11.2 per 100,000, and 0.8 per 100,000, respectively. When directly age-standardized to the World Health Organization standard population the overall IBD incidence rate was 29.6 per 100,000.
CONCLUSIONS: This is the first prospective, Australian population-based IBD incidence study. The incidence rates are among the highest reported in the literature of IBD.

Entities:  

Mesh:

Year:  2010        PMID: 20803698     DOI: 10.1002/ibd.21209

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  33 in total

Review 1.  An update of the role of nutritional therapy in the management of Crohn's disease.

Authors:  Moftah H Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  J Gastroenterol       Date:  2012-06-15       Impact factor: 7.527

2.  Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania.

Authors:  Gabriela Dumitrescu; Catalina Mihai; Mihaela Dranga; Cristina Cijevschi Prelipcean
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

3.  Incidence and Prevalence of Crohn's Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010.

Authors:  Raina Shivashankar; William J Tremaine; W Scott Harmsen; Edward V Loftus
Journal:  Clin Gastroenterol Hepatol       Date:  2016-11-14       Impact factor: 11.382

Review 4.  Is There a Link Between H. Pylori and the Epidemiology of Crohn's Disease?

Authors:  Ayesha Shah; Nicholas J Talley; Marjorie Walker; Natasha Koloski; Mark Morrison; Daniel Burger; Jane M Andrews; Michael McGuckin; Mike Jones; Gerald Holtmann
Journal:  Dig Dis Sci       Date:  2017-03-09       Impact factor: 3.199

5.  Accuracy of point-of-care intestinal ultrasound for Crohn's disease.

Authors:  Emily K Wright; Ian Wang; Darren Wong; Sally J Bell; William R Connell; Alexander J Thompson; Kerri L Novak; Michael A Kamm
Journal:  Australas J Ultrasound Med       Date:  2020-07-24

Review 6.  Epidemiological studies of migration and environmental risk factors in the inflammatory bowel diseases.

Authors:  Yanna Ko; Rhys Butcher; Rupert W Leong
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

7.  Live and heat-killed probiotic: effects on chronic experimental colitis induced by dextran sulfate sodium (DSS) in rats.

Authors:  Li-Xuan Sang; Bing Chang; Bing-Yuan Wang; Wei-Xin Liu; Min Jiang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

8.  A comparison of Australian chronic disease prevalence estimates using administrative pharmaceutical dispensing data with international and community survey data.

Authors:  Shaun Francis Purkiss; Tessa Keegel; Hassan Vally; Dennis Wollersheim
Journal:  Int J Popul Data Sci       Date:  2020-12-11

9.  An Australian Real-World Study of Treatment Persistence of Ustekinumab in Crohn's Disease.

Authors:  Tzu Hsiang Chien; Andrea Puig; Thang Khuong; Mahsa H Kouhkamari; Samuel Che; Tom Hsun-Wei Huang
Journal:  Biologics       Date:  2021-06-16

10.  Emerging inflammatory bowel disease in saudi outpatients: a report of 693 cases.

Authors:  Mohammad A Al-Mofarreh; Ibrahim A Al-Mofleh
Journal:  Saudi J Gastroenterol       Date:  2013 Jan-Feb       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.